Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F. Feu, E. Brullet, X. Calvet, J. Fernández-Llamazares, J. Guardiola, P. Moreno, et al.
Recomendaciones para el diagnóstico y el tratamiento de la hemorragia digestiva alta aguda no varicosa.
Gastroenterol Hepatol, 26 (2003), pp. 70-85
[2.]
M. Bustamante Balena, J. Ponce García.
Tratamiento antisecretor de la hemorragia digestiva por úlcera péptica: una aproximación a la evidencia disponible.
Rev Clin Esp, 204 (2004), pp. 161-168
[3.]
C.S. Huang, D.R. Lichtenstein.
Nonvariceal upper gastrointestinal bleeding.
Gastroenterol Clin North Am, 32 (2003), pp. 1053-1078
[4.]
Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut. 2002;51 Suppl 4:1-6.
[5.]
A. Barkun, M. Bardou, J.K. Marshall.
Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.
Ann Intern Med, 139 (2003), pp. 843-857
[6.]
K. Palmer.
Management of haematemesis and melaena.
Postgrad Med J, 80 (2004), pp. 399-404
[7.]
J. Higham, J.Y. Kang, A. Majeed.
Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.
Gut, 50 (2002), pp. 460-464
[8.]
R. Collins, M. Langman.
Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials.
N Engl J Med, 313 (1985), pp. 660-666
[9.]
A. Falk, N. Darle, U. Haglund, A. Tornqvist.
Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.
Scand J Gastroenterol, 110 (1985), pp. 95-100
[10.]
N.M. Selby, A.K. Kubba, C.J. Hawkey.
Acid suppression in peptic ulcer haemorrhage: a meta-analysis.
Aliment Pharmacol Ther, 14 (2000), pp. 1119-1126
[11.]
J.E. Levine, G.I. Leontiadis, V.K. Sharma, C.W. Howden.
Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer.
Aliment Pharmacol Ther, 16 (2002), pp. 1137-1142
[12.]
J.P. Gisbert.
Pharmacological treatment of bleeding peptic ulcer.
Med Clin (Barc), 127 (2006), pp. 66-75
[13.]
G.I. Leontiadis, L. McIntyre, V.K. Sharma, C.W. Howden.
Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Cochrane Database Syst Rev, (2004),
[14.]
G.I. Leontiadis, V.K. Sharma, C.W. Howden.
Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding.
BMJ, 12 (2005), pp. 568-570
[15.]
P.J. Zed, P.S. Loewen, R.S. Slavik, C.A. Marra.
Meta-analysis of proton pump inhibitors in treatment of bleeding peptic ulcers.
Ann Pharmacother, 35 (2001), pp. 1528-1534
[16.]
M.S. Khuroo, K.L. Farahat, I.E. Kagevi.
Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
J Gastroenterol Hepatol, 20 (2005), pp. 11-25
[17.]
J.P. Gisbert, L. González, X. Calvet, M. Roque, R. Gabriel, J.M. Pajares.
Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Aliment Pharmacol Ther, 15 (2001), pp. 917-926
[18.]
R.A. Enns, Y.M. Gagnon, K.P. Rioux, A.R. Levy.
Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
Aliment Pharmacol Ther, 17 (2003), pp. 225-233
[19.]
M. Naunton, G.M. Peterson, M.D. Bleasel.
Overuse of proton pump inhibitors.
J Clin Pharm Ther, 25 (2000), pp. 333-340
[20.]
R. Enns, C.N. Andrews, M. Fishman, M. Hahn, K. Atkinson, P. Kwan, et al.
Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Can J Gastroenterol, 18 (2004), pp. 567-571
[21.]
Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [citado May 2005].
The Cochrane Library, Issue 3,
[22.]
T.K. Daneshmend, C.J. Hawkey, M.J. Langman, R.F. Logan, R.G. Long, R.P. Walt.
Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial.
BMJ, 304 (1992), pp. 143-147
[23.]
G.M. Hawkey, A.T. Cole, A.S. McIntyre, R.G. Long, C.J. Hawkey.
Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points.
Gut, 49 (2001), pp. 372-379
[24.]
S. Hulagu, L. Demirturk, S. Gul, Y. Yazgan, M. Altin, M. Danaci.
The effect of omeprazole or ranitidine intravenous on upper gastrointestinal bleeding.
Endoskop J, 2 (1995), pp. 35-43
[25.]
J.Y. Lau, W.K. Leung, J.C. Wu, F.K. Chan, V.W. Wong, P.W. Chiu, et al.
Omeprazole before endoscopy in patients with gastrointestinal bleeding.
N Engl J Med, 356 (2007), pp. 1631-1640
[26.]
G. Wallner, A. Cienchanski, A. Wesolowski-Sory, P. Misiuna.
Treatment of acute upper gastrointestinal bleeding with intravenous omeprazole or ranitidine.
Eur J Clin Res, 8 (1996), pp. 235-243
[27.]
B.M. Garvey, J.A. McCambley, D.V. Tuxen.
Effects of gastric alkalization on bacterial colonization in critically ill patients.
Crit Care Med, 17 (1989), pp. 211-216
[28.]
L. Keyvani, S. Murthy, S. Leeson, L.E. Targownik.
Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Aliment Pharmacol Ther, 24 (2006), pp. 1247-1255
[29.]
C.N. Andrews, A. Levy, M. Fishman, M. Hahn, K. Atkinson, P. Kwan, et al.
Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Can J Gastroenterol, 19 (2005), pp. 667-671
[30.]
Y.M. Gagnon, A.R. Levy, M.A. Eloubeidi, M.R. Arguedas, K.P. Rioux, R.A. Enns.
Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding.
Value Health, 6 (2003), pp. 457-465
[31.]
K.K. Lee, J.H. You, I.C. Wong, S.K. Kwong, J.Y. Lau, T.Y. Chan, et al.
Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer.
Gastrointest Endosc, 57 (2003), pp. 160-164
[32.]
A.N. Barkun, K. Herba, V. Adam, W. Kennedy, C.A. Fallone, M. Bardou.
The cost-effectiveness of high-dose oral proton pump inhibition after endoscopy in the acute treatment of peptic ulcer bleeding.
Aliment Pharmacol Ther, 20 (2004), pp. 195-202
[33.]
A.N. Barkun, K. Herba, V. Adam, W. Kennedy, C.A. Fallone, M. Bardou.
High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis.
Aliment Pharmacol Ther, 19 (2004), pp. 591-600
[34.]
B.L. Erstad.
Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding.
Crit Care Med, 32 (2004), pp. 1277-1283
[35.]
B.M. Spiegel, J.J. Ofman, K. Woods, N.B. Vakil.
Minimizing recurrent peptic ulcer hemorrhage after endoscopic hemostasis: the cost-effectiveness of competing strategies.
Am J Gastroenterol, 98 (2003), pp. 86-97
[36.]
A.N. Barkun, A.W. Cockeram, V. Plourde, R.N. Fedorak.
Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding.
Aliment Pharmacol Ther, 13 (1999), pp. 1565-1584
[37.]
H.C. Cheng, S.A. Chuang, Y.H. Kao, A.W. Kao, C.H. Chuang, B.S. Sheu.
Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.
Hepatogastroenterology, 50 (2003), pp. 2270-2273
CIBEREHD está financiada por el Instituto de Salud Carlos III.
Copyright © 2008. Elsevier España S.L.. Todos los derechos reservados
